Cargando…

CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects

Tumor-associated macrophages (TAMs)-based immunotherapy is a promising strategy. Since TAMs are mainly composed of M2-type macrophages, they have a promoting effect on tumor growth, invasion, and metastasis. M2-type macrophages contain a specific receptor CD163 on their surface, providing a prerequi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zun, Li, Haijiao, Zhang, Wenrui, Zhang, Mingzu, He, Jinlin, Yu, Zepeng, Sun, Xingwei, Ni, Peihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144748/ https://www.ncbi.nlm.nih.gov/pubmed/37111726 http://dx.doi.org/10.3390/pharmaceutics15041241

Ejemplares similares

Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells
por: Zhou, Ru, et al.
Publicado: (2022)

The Clinical Significance of CD163+ Tumor-Associated Macrophages (TAMs) in Laryngeal Squamous Cell Carcinoma
por: Ouban, Abderrahman, et al.
Publicado: (2023)

Molecular mechanism of CD163(+) tumor-associated macrophage (TAM)-derived exosome-induced cisplatin resistance in ovarian cancer ascites
por: Zhang, Xiaohui, et al.
Publicado: (2022)

Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
por: Etzerodt, Anders, et al.
Publicado: (2019)

Versatile Construction of Single-Tailed Giant Surfactants with Hydrophobic Poly(ε-caprolactone) Tail and Hydrophilic POSS Head
por: Qian, Qiangyu, et al.
Publicado: (2019)

Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma
por: Badawi, Manal A., et al.
Publicado: (2015)

Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas
por: Anagnostakis, Filippos, et al.
Publicado: (2023)

The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy
por: Ge, Zhe, et al.
Publicado: (2020)

The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
por: Yang, Qiyao, et al.
Publicado: (2020)

Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review
por: Räihä, Meri R., et al.
Publicado: (2018)

Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer
por: Shinohara, Hajime, et al.
Publicado: (2022)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis
por: Wang, Hui, et al.
Publicado: (2021)

Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects
por: Zhang, Jiatong, et al.
Publicado: (2022)

Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
por: Yin, Meichen, et al.
Publicado: (2019)

Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting role
por: Yu, Junhui, et al.
Publicado: (2021)

DICERing macrophages for reprogramming TAMs
por: Squadrito, Mario Leonardo, et al.
Publicado: (2016)

Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer
por: Xue, Tao, et al.
Publicado: (2021)

Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2017)

Magnetic resonance imaging of tumor-associated-macrophages (TAMs) with a nanoparticle contrast agent
por: Zhou, Junhan, et al.
Publicado: (2022)

Secretion of BMP-2 by tumor-associated macrophages (TAM) promotes microcalcifications in breast cancer
por: Wang, Shuo, et al.
Publicado: (2022)

Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells
por: Liu, Xiaojin, et al.
Publicado: (2022)

Isolation and separation of murine tumor-associated macrophages (TAMs) subpopulations from orthotopic 4T1 breast tumors
por: Bieniasz-Krzywiec, Pawel, et al.
Publicado: (2021)

Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma
por: Caillou, Bernard, et al.
Publicado: (2011)

Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis
por: Furuya, Mitsuko, et al.
Publicado: (2012)

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
por: Myers, Kayla V., et al.
Publicado: (2019)

Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy
por: Wang, Stephanie J., et al.
Publicado: (2020)

Regulation of tumor-associated macrophage (TAM) differentiation by NDRG2 expression in breast cancer cells
por: Lee, Soyeon, et al.
Publicado: (2022)

Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates
por: Perreault, Mylène, et al.
Publicado: (2013)

Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
por: Yang, Wenjie, et al.
Publicado: (2020)

CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
por: Harris, Jonathan A, et al.
Publicado: (2012)

CD47 expression and CD163(+) macrophages correlated with prognosis of pancreatic neuroendocrine tumor
por: Imam, Rami, et al.
Publicado: (2021)

The Role of TAMs in Tumor Microenvironment and New Research Progress
por: Feng, Yawei, et al.
Publicado: (2022)

Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2022)

Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors
por: Omatsu, Mutsuko, et al.
Publicado: (2014)

Emerging neo adjuvants for harnessing therapeutic potential of M1 tumor associated macrophages (TAM) against solid tumors: Enusage of plasticity
por: Nadella, Vinod, et al.
Publicado: (2020)

CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis
por: Ni, Chao, et al.
Publicado: (2019)

The correlation between infiltration of FoxP3(+) Tregs, CD66b(+) TANs and CD163(+) TAMs in colorectal cancer
por: Ren, Yuehan, et al.
Publicado: (2022)

Targeting Gas6/TAM in cancer cells and tumor microenvironment
por: Wu, Guiling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qk2ff29jet419e9lrmrro5onkf